Compound information
- Natural Products
- ZC60845
- Molecular Formula
- C10H15NO3
- Molecular Weight
- 197.10519334 g/mol
- Structure
-
- IUPAC Name
- 1-(6-hydroxyhexyl)pyrrole-2,5-dione
- InChI
- InChI=1S/C10H15NO3/c12-8-4-2-1-3-7-11-9(13)5-6-10(11)14/h5-6,12H,1-4,7-8H2
- InChI Key
- SVMIVBMALOISKL-UHFFFAOYSA-N
- SMILES
- O=C1C=CC(=O)N1CCCCCCO
- Source
- ZINC000038885195
Warheads
- Acrylamide
-
- Acrylamide
-
ADMET Property
Physicochemical Property
Property | Value | Property | Value |
---|---|---|---|
Heavy Atom Count | 14 | Ring Count | 1 |
Heteroatom Count | 4 | Rotatable Bond Count | 6 |
Hydrogen Bond Acceptor Count | 3 | Hydrogen Bond Donor Count | 1 |
Topological Polar Surface Area | 57.61 Å2 | LogP | 0.541 |
LogS | -1.794 | LogD | 0.329 |
Absorption
Property | Value | Property | Value |
---|---|---|---|
Pgp inhibitor | 0.109 | Pgp substrate | 0.147 |
HIA | 0.58 | F20 % | 0.889 |
F30 % | 0.009 | Caco-2 | -4.755 |
MDCK | -4.506 |
Distribution
Property | Value | Property | Value |
---|---|---|---|
BBB Penetration | 0.754 | PPB | 58.595 |
VD | 0.52 | Fu | 0.382 |
Metabolism
Property | Value | Property | Value |
---|---|---|---|
CYP1A2 inhibitor | 0.139 | CYP1A2 substrate | 0.51 |
CYP2A6 substrate | 0.472 | CYP2B6 substrate | 0.535 |
CYP2C19 inhibitor | 0.116 | CYP2C19 substrate | 0.406 |
CYP2C8 substrate | 0.516 | CYP2C9 inhibitor | 0.099 |
CYP2C9 substrate | 0.012 | CYP2D6 inhibitor | 0.015 |
CYP2D6 substrate | 0.102 | CYP2E1 substrate | 0.702 |
CYP3A4 inhibitor | 0.027 | CYP3A4 substrate | 0.084 |
Excretion
Property | Value | Property | Value |
---|---|---|---|
T1/2 | 0.789 | CL | 6.228 |
Toxicity
Property | Value | Property | Value |
---|---|---|---|
hERG Blockers | 0.015 | Hepatotoxicity | 0.3 |
Mutagenicity | 0.002 | Rat Oral Acute Toxicity | 0.113 |
FDAMDD | 0.207 | Skin Sensitization | 0.971 |
Carcinogenicity | 0.2 | Eye Corrosion | 0.372 |
Eye Irritation | 0.978 | Respiratory Toxicity | 0.024 |
Environmental Toxicity
Property | Value | Property | Value |
---|---|---|---|
Bioconcentration Factors | 0.246 | IGC50 | 2.76 |
LC50FM | 2.505 | LC50DM | 3.095 |
Tox21 Pathway
Property | Value | Property | Value |
---|---|---|---|
NR-AR | 0.09 | NR-AR-LBD | 0.248 |
NR-AhR | 0.005 | NR-Aromatase | 0.196 |
NR-ER | 0.211 | NR-ER-LBD | 0.344 |
NR-PPAR-gamma | 0.738 | SR-ARE | 0.828 |
SR-ATAD5 | 0.521 | SR-HSE | 0.891 |
SR-MMP | 0.082 | SR-p53 | 0.732 |
Similar covalent inhibitors
Similar covalent drugs
No similar covalent drugs found for this compound.